|
|
Botox Provides Long-Term Symptomatic Relief of Benign Prostatic Hypertrophy
|
| Link ID |
13332 |
| Title |
Botox Provides Long-Term Symptomatic Relief of Benign Prostatic Hypertrophy |
| Url |
http://www.medscape.com/viewarticle/588061?src=rss |
| Description |
Intraprostatic botulinum toxin injections for treatment of benign prostatic hypertrophy relieves symptoms for up to 30 months, physicians in Italy report. This treatment is also associated with sustained reductions in prostatic volume and in serum prostate specific antigen (PSA) levels, indicating a possible anticancer effect. Reuters Health Information |
| Category |
Articles > Pharmacists |
| Keywords |
|
| Date |
Feb 12, 2009 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Pharmacists |
| 1. |
Everolimus Effective in Rheumatoid Arthritis Patients
|
|
|
The proliferation signal inhibitor everolimus is effective and safe in rheumatoid arthritis (RA) patients who have an inadequate response to methotrexate, according to trial results reported in the August issue of the Annals of the Rheumatic Diseases. However, development of everolimus for this indication is not being pursued. Reuters Health Information
|
| 5. |
Batches of Velcade (bortezomib) Recalled
|
|
|
Johnson & Johnson and Millennium Pharmaceuticals are recalling thousands of vials of Velcade (bortezomib) sold in Europe, the United States, Japan and Malaysia after receiving reports of white particles seen floating in vials of the medicine. Reuters Health Information
|
|
|
